COMPOUND HAVING MELANIN PRODUCTION INHIBITORY ACTION, COLLAGEN PRODUCTION PROMOTING ACTION, AND WOUND HEALING PROMOTING ACTION
PROBLEM TO BE SOLVED: To provide a compound having a melanin production inhibitory action, a collagen production promoting action, and a wound healing promoting action.SOLUTION: According to the present invention, based on the experimental results, the compound represented by Chemical Formula I desc...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
16.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide a compound having a melanin production inhibitory action, a collagen production promoting action, and a wound healing promoting action.SOLUTION: According to the present invention, based on the experimental results, the compound represented by Chemical Formula I described below has a high inhibitory action, particularly to suppress the gene expression level of MMP-9 and the gene expression level of MITF in human skin fibroblasts. In addition to significantly suppress the gene expression level of MMP-9 and the gene expression level of MITFT, the compound causes an increase in amount of collagen produced in human fibroblasts and suppresses melanin in human fibroblasts.SELECTED DRAWING: Figure 1
【課題】メラニン産生抑制作用、コラーゲン産生促進作用及び創傷治癒促進作用を有する化合物を提供する。【解決手段】実験結果により、下記化学式Iで示される化合物は特にヒト皮膚線維芽細胞におけるMMP−9の遺伝子発現量及びMITFの遺伝子発現量を抑制する高い抑制活性を有していることが実証された。また、該化合物によれば、MMP−9の遺伝子発現量及びMITFの遺伝子発現量が著しく抑制されると共に、ヒト線維芽細胞におけるコラーゲンの産生量も向上し、且つヒト線維芽細胞におけるメラニンも抑制される。【化1】【選択図】図1 |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide a compound having a melanin production inhibitory action, a collagen production promoting action, and a wound healing promoting action.SOLUTION: According to the present invention, based on the experimental results, the compound represented by Chemical Formula I described below has a high inhibitory action, particularly to suppress the gene expression level of MMP-9 and the gene expression level of MITF in human skin fibroblasts. In addition to significantly suppress the gene expression level of MMP-9 and the gene expression level of MITFT, the compound causes an increase in amount of collagen produced in human fibroblasts and suppresses melanin in human fibroblasts.SELECTED DRAWING: Figure 1
【課題】メラニン産生抑制作用、コラーゲン産生促進作用及び創傷治癒促進作用を有する化合物を提供する。【解決手段】実験結果により、下記化学式Iで示される化合物は特にヒト皮膚線維芽細胞におけるMMP−9の遺伝子発現量及びMITFの遺伝子発現量を抑制する高い抑制活性を有していることが実証された。また、該化合物によれば、MMP−9の遺伝子発現量及びMITFの遺伝子発現量が著しく抑制されると共に、ヒト線維芽細胞におけるコラーゲンの産生量も向上し、且つヒト線維芽細胞におけるメラニンも抑制される。【化1】【選択図】図1 |
Author | LIN YONGXIANG SU XIANGLING |
Author_xml | – fullname: LIN YONGXIANG – fullname: SU XIANGLING |
BookMark | eNrjYmDJy89L5WSoc_b3DfAP9XNR8HAM8_RzV_B19XH08_RTCAjydwl1DvH091Pw9PPwdPIM8Q-KVHAEi-goOPv7-Di6u6IoAzJ9_UNAZsBUOQKNDYcY7uroA5JBV8PDwJqWmFOcyguluRmU3FxDnD10Uwvy41OLCxKTU_NSS-K9AowMDM0NjM2MzEwdjYlSBAA3JT45 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | メラニン産生抑制作用、コラーゲン産生促進作用及び創傷治癒促進作用を有する化合物 |
ExternalDocumentID | JP2017036265A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2017036265A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:30:15 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Japanese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2017036265A3 |
Notes | Application Number: JP20160151246 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&CC=JP&NR=2017036265A |
ParticipantIDs | epo_espacenet_JP2017036265A |
PublicationCentury | 2000 |
PublicationDate | 20170216 |
PublicationDateYYYYMMDD | 2017-02-16 |
PublicationDate_xml | – month: 02 year: 2017 text: 20170216 day: 16 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | TCI CO LTD |
RelatedCompanies_xml | – name: TCI CO LTD |
Score | 3.1960032 |
Snippet | PROBLEM TO BE SOLVED: To provide a compound having a melanin production inhibitory action, a collagen production promoting action, and a wound healing... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS SPIRITS VINEGAR WINE |
Title | COMPOUND HAVING MELANIN PRODUCTION INHIBITORY ACTION, COLLAGEN PRODUCTION PROMOTING ACTION, AND WOUND HEALING PROMOTING ACTION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&locale=&CC=JP&NR=2017036265A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT8IwFH5BNOpNUaOipjFmJxetbCM7EDO6wUbYuiwb4olso0vUBIjMePO32xZQ9MCt7Xv5krZ5fe3r61eAm5w9ZAwXDdVg2FQ1lmIRaMpU7ipNPM41nEmebj8w3ETrDfVhBd5Wb2EkT-inJEfkFpVzey_lej37DWLZMrdyfpe98KbpYydu2crydIyb3GUZit1uOSG1KVEIafVCJYgWMkG9oltbsC320YJo3xm0xbOU2bpP6RzATsjhJuUhVF7TGuyR1ddrNdj1lzfevLg0vvkRfBHqhzQJbORaAy_oIl98d-EFKIyonchkEOQFrtf2Yho9o0V6yC0itN-3us4fNV70aSwwVloWh31agDtWX0j-6xzDdceJiavyjox-hm3UC9c63TiB6mQ6YaeA9LFWFIWp69l9oWEzTZt5U8RC-azpjJ--zqC-Aeh8o7QO-6Im0pqxcQHV8v2DXXKvXWZXcrS_AaAPkeI |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOJNUaPiR2PMTi5a2Ud2IGZ0gw23dSED4US2sSVqAkRmvPm32xZQ9MCt6Xv5pR95fe3r668AN2n2kGQ4r8tahg1ZyWLMA02JzFylgcepghPB0-0HmtNTOgN1UIK31VsYwRP6KcgRmUWlzN4LsV7PfoNYlsitnN8lL6xq-tiKGpa0PB1jnbksTbKaDTukFiUSIY1OKAXdhYxTr6jmFmzrnJ6X7536Tf4sZbbuU1r7sBMyuElxAKXXuAoVsvp6rQq7_vLGmxWXxjc_hC9C_ZD2Ags5Zt8N2sjn3124AQq71OqJZBDkBo7bdCPaHaJFesgtItTzzLb9R40VfRpxjJWWyWCfF-C26XHJf50juG7ZEXFk1pHRz7CNOuFap-vHUJ5MJ9kJIHWs5HluqGpynyvYiGM91XkslM2amrHT1ynUNgCdbZReQcWJfG_E2vlUgz0u4SnOWDuHcvH-kV0wD14kl2LkvwGcS5TP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUND+HAVING+MELANIN+PRODUCTION+INHIBITORY+ACTION%2C+COLLAGEN+PRODUCTION+PROMOTING+ACTION%2C+AND+WOUND+HEALING+PROMOTING+ACTION&rft.inventor=LIN+YONGXIANG&rft.inventor=SU+XIANGLING&rft.date=2017-02-16&rft.externalDBID=A&rft.externalDocID=JP2017036265A |